Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$282K Hold
1,540
0.14% 143
2025
Q4
$271K Hold
1,540
0.12% 145
2025
Q3
$216K Buy
+1,540
New +$208K 0.1% 183
2024
Q3
Sell
-1,050
Closed -$243K 157
2024
Q2
$243K Buy
+1,050
New +$228K 0.14% 122
2023
Q1
Sell
-810
Closed -$224K 123
2022
Q4
$224K Buy
+810
New +$229K 0.2% 103

Other funds holding BIIB

Alpha Family Trust's BIIB Position: Q1 2026 in Review

Alpha Family Trust held its Biogen (BIIB) position steady in Q1 2026 at 1,540 shares worth $282K. The position accounts for 0.14% of the portfolio, ranked #143.

Alpha Family Trust first reported a position in BIIB in Q4 2022 and has held it in 5 quarters since. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Alpha Family Trust held 1,540 shares of Biogen worth $282K as of Q1 2026.
  • Alpha Family Trust left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.14% of Alpha Family Trust's portfolio in Q1 2026, its #143 holding.
  • Alpha Family Trust first reported a position in Biogen in Q4 2022 and has held it in 5 quarters since.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.